| Product Information |
|
| Registration Number |
BR-659
|
| Generic Name |
Diphtheria, Tetanus, Acellular Pertussis, Inactivated
Poliomyelitis and Haemophilus influenzae Type B
Conjugate Vaccine, Adsorbed
|
| Brand Name |
Infanrix-IPV+Hib
|
| Dosage Strength |
0.5 mL
|
| Dosage Form |
Suspension For Injection (Deep I.M.), 2PE Free
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
-
|
| Packaging |
1 ml Type I Glass Pre-filled Syringe with Two (2)
separate Sterile Needle [256 x 1"] + Hib Lyophilized Powder for Injection in 3 mL Type I Glass Vial (Box of 1's)
|
| Manufacturer |
GlaxoSmithKline Biologicals SA
|
| Country of Origin |
Belgium
|
| Trader |
|
| Importer |
GlaxoSmithKline Philippines, Inc.
|
| Distributor |
|
| Application Type |
-
|
| Issuance Date |
26 February 2021
|
| Expiry Date |
19 July 2025
|